Machine Learning Algorithms for Prediction of Biological

Total Page:16

File Type:pdf, Size:1020Kb

Machine Learning Algorithms for Prediction of Biological MACHINE LEARNING ALGORITHMS FOR PREDICTION OF BIOLOGICAL ACTIVITY AND CHEMICAL PROPERTIES By Ralf Mueller Dissertation Submitted to the Faculty of the Graduate School of Vanderbilt University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY In Chemistry August, 2011 Nashville, Tennessee Approved: Professor Jens Meiler Professor Brian Bachmann Professor Prasad Polavarapu Professor Dave Weaver DEDICATION To my wife, my parents, and my grandfather. ii ACKNOWLEDGMENTS First I would like to acknowledge my advisor Jens Meiler, Ph.D. for giving me the opportunity to work on these projects, valuable input, and great discussions. Furthermore I would like to acknowledge my committee for keeping me on track and my co-workers Kristian Kaufmann, Eric Dawson, and Nils Woetzel for fruitful discussions. I thank the Conn lab in collaboration with Craig Lindsley and Dave Weaver for providing me the experimental data for the virtual high-throughput screening experiments. Financial support was granted by the National Institute of Health and the Vanderbilt Institute for Chemical Biology. Lastly, I would like to thank my wife and my family for their unwavering support over four continents. iii TABLE OF CONTENTS Page DEDICATION .............................................................................................................................. ii ACKNOWLEDGEMENTS ......................................................................................................... iii TABLE OF CONTENTS ............................................................................................................ iv LIST OF TABLES ..................................................................................................................... xiii LIST OF FIGURES ................................................................................................................... xiv LIST OF ABBREVIATIONS.................................................................................................... xvi SUMMARY............................................................................................................................. xviii Chapter I. INTRODUCTION .............................................................................................................. 1 Quantitative Structure Activity Relationships .............................................................. 1 Quantitative Structure Property Relationships ............................................................. 1 QSAR/QSPR through machine learning ...................................................................... 1 QSAR/QSPR general workflow ................................................................................... 2 Identifying publicly and commercially available carbon chemical shift data bases .... 2 Local high-throughput screens provided small molecule activity data towards mGlu4/5 ........................................................................................................................ 2 Commercial ADRIANA descriptors were developed into atom-based descriptors ..... 3 Small molecule conformations were computed with CORINA ................................... 3 iv Constitutional chemical shift descriptors based on atom/bond types and ring closure 3 Strong synergy between QSAR and QSPR projects .................................................... 4 Neural Networks as robust tools for QSAR/QSPR ...................................................... 4 Allosteric modulation of metabotropic glutamate receptors ........................................ 5 High-throughput screens in drug discovery ................................................................. 5 Virtual high-throughput screens ................................................................................... 6 Positive allosteric modulation of metabotropic glutamate receptor subtype 5 ............. 7 Positive allosteric modulation of metabotropic glutamate receptor subtype 4 ............. 8 Negative allosteric modulation of metabotropic glutamate receptor subtype 5 ........... 9 Prediction of carbon chemical shift ............................................................................ 10 II. IDENTIFICATION OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 5 POTENTIATORS USING VIRTUAL HIGH-THROUGHPUT SCREENING .............. 13 Introduction ................................................................................................................ 13 Activators of mGlu5 may provide a novel approach to treatment of schizophrenia ............................................................................................................................. 14 High-throughput screening in drug discovery ..................................................... 15 Quantitative structure activity relations in drug discovery .................................. 15 Numerical descriptors of chemical structure for QSARs..................................... 16 Fragment-independent transformation-invariant descriptor schemes .................. 17 Application of machine learning algorithms to establish QSARs ....................... 18 Quantitative structure activity relation models for mGlu5 positive allosteric modulation ........................................................................................................... 18 v Results and Discussion ............................................................................................... 19 Discussion of concentration response curves in the experimental high-throughput screen ................................................................................................................... 19 Input sensitivity is a reliable measure to prioritize descriptors ............................ 20 Optimization of molecular descriptor set improves prediction accuracy of the ANN model .......................................................................................................... 21 Balancing the datasets through oversampling yields better results than two undersampling strategies ...................................................................................... 26 Radial distribution functions and electronegativity contribute most to an accurate prediction ............................................................................................................. 28 Virtual screening of ChemBridge compound library ........................................... 30 Analysis of the newly identified set of mGlu5 potentiators ................................. 31 Major scaffolds are evenly distributed throughout training, monitoring, and independent datasets ............................................................................................ 31 The majority of hit compounds share a scaffold with previously identified potentiator compounds ......................................................................................... 32 Benzamides, benzoxazepines, and MPEP-like compounds are enriched among active compounds in the post-screen ................................................................... 32 Inactive compounds in the post-screen library contain 53 % benzamides, benzoxazepines, and MPEP-like compounds ...................................................... 33 Significant numbers of hit compounds are non-trivial modifications of original HTS screen hits .................................................................................................... 34 vi High potency cutoff may introduce bias to close derivatives of original HTS screen hit compounds ........................................................................................... 34 Fragment-independent numerical description deals efficiently with multiple scaffolds ............................................................................................................... 35 Conclusions ................................................................................................................ 35 Methods ...................................................................................................................... 36 Experimental high-throughput screen for mGlu5 potentiators and hit validation 36 Generation of numerical descriptors for training of QSAR models .................... 39 Oversampling was used for balanced training ..................................................... 40 A monitoring dataset was introduced to early terminate ANN training .............. 41 Artificial neural network (ANN) architecture and training ................................. 42 Selection of the optimal set of descriptors of chemical structure ........................ 43 Enrichment and area under the curve as quality measures ....................... 45 Implementation .................................................................................................... 47 III. VIRTUAL HIGH-THROUGHPUT SCREENING AS A ROBUST TOOL TO IDENTIFY METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 4 POTENTIATORS ............................................................................................................. 48 Introduction ................................................................................................................ 48 Results and Discussion ............................................................................................... 50 Descriptor categories were selected according to input sensitivity ..................... 50 Optimization of molecular descriptor set improves prediction results ................ 51 Jury
Recommended publications
  • Infiltrating Myeloid Cells Drive Osteosarcoma Progression Via GRM4 Regulation of IL23
    Published OnlineFirst September 16, 2019; DOI: 10.1158/2159-8290.CD-19-0154 RESEARCH BRIEF Infi ltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23 Maya Kansara 1 , 2 , Kristian Thomson 1 , Puiyi Pang 1 , Aurelie Dutour 3 , Lisa Mirabello 4 , Francine Acher5 , Jean-Philippe Pin 6 , Elizabeth G. Demicco 7 , Juming Yan 8 , Michele W.L. Teng 8 , Mark J. Smyth 9 , and David M. Thomas 1 , 2 ABSTRACT The glutamate metabotropic receptor 4 (GRM4 ) locus is linked to susceptibility to human osteosarcoma, through unknown mechanisms. We show that Grm4 − / − gene– targeted mice demonstrate accelerated radiation-induced tumor development to an extent comparable with Rb1 +/ − mice. GRM4 is expressed in myeloid cells, selectively regulating expression of IL23 and the related cytokine IL12. Osteosarcoma-conditioned media induce myeloid cell Il23 expression in a GRM4-dependent fashion, while suppressing the related cytokine Il12 . Both human and mouse osteosarcomas express an increased IL23:IL12 ratio, whereas higher IL23 expression is associated with worse survival in humans. Con- sistent with an oncogenic role, Il23−/− mice are strikingly resistant to osteosarcoma development. Agonists of GRM4 or a neutralizing antibody to IL23 suppressed osteosarcoma growth in mice. These fi ndings identify a novel, druggable myeloid suppressor pathway linking GRM4 to the proinfl ammatory IL23/IL12 axis. SIGNIFICANCE: Few novel systemic therapies targeting osteosarcoma have emerged in the last four decades. Using insights gained from a genome-wide association study and mouse modeling, we show that GRM4 plays a role in driving osteosarcoma via a non–cell-autonomous mechanism regulating IL23, opening new avenues for therapeutic intervention.
    [Show full text]
  • Metabotropic Glutamate Receptors
    mGluR Metabotropic glutamate receptors mGluR (metabotropic glutamate receptor) is a type of glutamate receptor that are active through an indirect metabotropic process. They are members of thegroup C family of G-protein-coupled receptors, or GPCRs. Like all glutamate receptors, mGluRs bind with glutamate, an amino acid that functions as an excitatoryneurotransmitter. The mGluRs perform a variety of functions in the central and peripheral nervous systems: mGluRs are involved in learning, memory, anxiety, and the perception of pain. mGluRs are found in pre- and postsynaptic neurons in synapses of the hippocampus, cerebellum, and the cerebral cortex, as well as other parts of the brain and in peripheral tissues. Eight different types of mGluRs, labeled mGluR1 to mGluR8, are divided into groups I, II, and III. Receptor types are grouped based on receptor structure and physiological activity. www.MedChemExpress.com 1 mGluR Agonists, Antagonists, Inhibitors, Modulators & Activators (-)-Camphoric acid (1R,2S)-VU0155041 Cat. No.: HY-122808 Cat. No.: HY-14417A (-)-Camphoric acid is the less active enantiomer (1R,2S)-VU0155041, Cis regioisomer of VU0155041, is of Camphoric acid. Camphoric acid stimulates a partial mGluR4 agonist with an EC50 of 2.35 osteoblast differentiation and induces μM. glutamate receptor expression. Camphoric acid also significantly induced the activation of NF-κB and AP-1. Purity: ≥98.0% Purity: ≥98.0% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10 mM × 1 mL, 100 mg Size: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg (2R,4R)-APDC (R)-ADX-47273 Cat. No.: HY-102091 Cat. No.: HY-13058B (2R,4R)-APDC is a selective group II metabotropic (R)-ADX-47273 is a potent mGluR5 positive glutamate receptors (mGluRs) agonist.
    [Show full text]
  • Kwame Nkrumah University of Science and Technology, Kumasi
    KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY, KUMASI, GHANA Assessing the Social Impacts of Illegal Gold Mining Activities at Dunkwa-On-Offin by Judith Selassie Garr (B.A, Social Science) A Thesis submitted to the Department of Building Technology, College of Art and Built Environment in partial fulfilment of the requirement for a degree of MASTER OF SCIENCE NOVEMBER, 2018 DECLARATION I hereby declare that this work is the result of my own original research and this thesis has neither in whole nor in part been prescribed by another degree elsewhere. References to other people’s work have been duly cited. STUDENT: JUDITH S. GARR (PG1150417) Signature: ........................................................... Date: .................................................................. Certified by SUPERVISOR: PROF. EDWARD BADU Signature: ........................................................... Date: ................................................................... Certified by THE HEAD OF DEPARTMENT: PROF. B. K. BAIDEN Signature: ........................................................... Date: ................................................................... i ABSTRACT Mining activities are undertaken in many parts of the world where mineral deposits are found. In developing nations such as Ghana, the activity is done both legally and illegally, often with very little or no supervision, hence much damage is done to the water bodies where the activities are carried out. This study sought to assess the social impacts of illegal gold mining activities at Dunkwa-On-Offin, the capital town of Upper Denkyira East Municipality in the Central Region of Ghana. The main objectives of the research are to identify factors that trigger illegal mining; to identify social effects of illegal gold mining activities on inhabitants of Dunkwa-on-Offin; and to suggest effective ways in curbing illegal mining activities. Based on the approach to data collection, this study adopts both the quantitative and qualitative approach.
    [Show full text]
  • Development of Allosteric Modulators of Gpcrs for Treatment of CNS Disorders Hilary Highfield Nickols A, P
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Neurobiology of Disease 61 (2014) 55–71 Contents lists available at ScienceDirect Neurobiology of Disease journal homepage: www.elsevier.com/locate/ynbdi Review Development of allosteric modulators of GPCRs for treatment of CNS disorders Hilary Highfield Nickols a, P. Jeffrey Conn b,⁎ a Division of Neuropathology, Department of Pathology, Microbiology and Immunology, Vanderbilt University, USA b Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA article info abstract Article history: The discovery of allosteric modulators of G protein-coupled receptors (GPCRs) provides a promising new strategy Received 25 July 2013 with potential for developing novel treatments for a variety of central nervous system (CNS) disorders. Tradition- Revised 13 September 2013 al drug discovery efforts targeting GPCRs have focused on developing ligands for orthosteric sites which bind en- Accepted 17 September 2013 dogenous ligands. Allosteric modulators target a site separate from the orthosteric site to modulate receptor Available online 27 September 2013 function. These allosteric agents can either potentiate (positive allosteric modulator, PAM) or inhibit (negative allosteric modulator, NAM) the receptor response and often provide much greater subtype selectivity than Keywords: Allosteric modulator orthosteric ligands for the same receptors. Experimental evidence has revealed more nuanced pharmacological CNS modes of action of allosteric modulators, with some PAMs showing allosteric agonism in combination with pos- Drug discovery itive allosteric modulation in response to endogenous ligand (ago-potentiators) as well as “bitopic” ligands that GPCR interact with both the allosteric and orthosteric sites. Drugs targeting the allosteric site allow for increased drug Metabotropic glutamate receptor selectivity and potentially decreased adverse side effects.
    [Show full text]
  • A Grid Algorithm for High Throughput Fitting of Dose-Response Curve Data Yuhong Wang*, Ajit Jadhav, Noel Southal, Ruili Huang and Dac-Trung Nguyen
    Current Chemical Genomics, 2010, 4, 57-66 57 Open Access A Grid Algorithm for High Throughput Fitting of Dose-Response Curve Data Yuhong Wang*, Ajit Jadhav, Noel Southal, Ruili Huang and Dac-Trung Nguyen National Institutes of Health, NIH Chemical Genomics Center, 9800 Medical Center Drive, Rockville, MD 20850, USA Abstract: We describe a novel algorithm, Grid algorithm, and the corresponding computer program for high throughput fitting of dose-response curves that are described by the four-parameter symmetric logistic dose-response model. The Grid algorithm searches through all points in a grid of four dimensions (parameters) and finds the optimum one that corre- sponds to the best fit. Using simulated dose-response curves, we examined the Grid program’s performance in reproduc- ing the actual values that were used to generate the simulated data and compared it with the DRC package for the lan- guage and environment R and the XLfit add-in for Microsoft Excel. The Grid program was robust and consistently recov- ered the actual values for both complete and partial curves with or without noise. Both DRC and XLfit performed well on data without noise, but they were sensitive to and their performance degraded rapidly with increasing noise. The Grid program is automated and scalable to millions of dose-response curves, and it is able to process 100,000 dose-response curves from high throughput screening experiment per CPU hour. The Grid program has the potential of greatly increas- ing the productivity of large-scale dose-response data analysis and early drug discovery processes, and it is also applicable to many other curve fitting problems in chemical, biological, and medical sciences.
    [Show full text]
  • GPCR/G Protein
    Inhibitors, Agonists, Screening Libraries www.MedChemExpress.com GPCR/G Protein G Protein Coupled Receptors (GPCRs) perceive many extracellular signals and transduce them to heterotrimeric G proteins, which further transduce these signals intracellular to appropriate downstream effectors and thereby play an important role in various signaling pathways. G proteins are specialized proteins with the ability to bind the nucleotides guanosine triphosphate (GTP) and guanosine diphosphate (GDP). In unstimulated cells, the state of G alpha is defined by its interaction with GDP, G beta-gamma, and a GPCR. Upon receptor stimulation by a ligand, G alpha dissociates from the receptor and G beta-gamma, and GTP is exchanged for the bound GDP, which leads to G alpha activation. G alpha then goes on to activate other molecules in the cell. These effects include activating the MAPK and PI3K pathways, as well as inhibition of the Na+/H+ exchanger in the plasma membrane, and the lowering of intracellular Ca2+ levels. Most human GPCRs can be grouped into five main families named; Glutamate, Rhodopsin, Adhesion, Frizzled/Taste2, and Secretin, forming the GRAFS classification system. A series of studies showed that aberrant GPCR Signaling including those for GPCR-PCa, PSGR2, CaSR, GPR30, and GPR39 are associated with tumorigenesis or metastasis, thus interfering with these receptors and their downstream targets might provide an opportunity for the development of new strategies for cancer diagnosis, prevention and treatment. At present, modulators of GPCRs form a key area for the pharmaceutical industry, representing approximately 27% of all FDA-approved drugs. References: [1] Moreira IS. Biochim Biophys Acta. 2014 Jan;1840(1):16-33.
    [Show full text]
  • Diamandis Thesis
    !"!#$ CHEMICAL GENETIC INTERROGATION OF NEURAL STEM CELLS: PHENOTYPE AND FUNCTION OF NEUROTRANSMITTER PATHWAYS IN NORMAL AND BRAIN TUMOUR INITIATING NEURAL PRECUSOR CELLS by Phedias Diamandis A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy. Department of Molecular Genetics University of Toronto © Copyright by Phedias Diamandis 2010 Phenotype and Function of Neurotransmitter Pathways in Normal and Brain Tumor Initiating Neural Precursor Cells Phedias Diamandis Doctor of Philosophy Department of Molecular Genetics University of Toronto 2010 &'(!)&*!% The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain brings promise for the treatment of neurological diseases and has yielded new insight into brain cancer. The complete repertoire of signaling pathways that governs these cells however remains largely uncharacterized. This thesis describes how chemical genetic approaches can be used to probe and better define the operational circuitry of the NSC. I describe the development of a small molecule chemical genetic screen of NSCs that uncovered an unappreciated precursor role of a number of neurotransmitter pathways commonly thought to operate primarily in the mature central nervous system (CNS). Given the similarities between stem cells and cancer, I then translated this knowledge to demonstrate that these neurotransmitter regulatory effects are also conserved within cultures of cancer stem cells. I then provide experimental and epidemiologically support for this hypothesis and suggest that neurotransmitter signals may also regulate the expansion of precursor cells that drive tumor growth in the brain. Specifically, I first evaluate the effects of neurochemicals in mouse models of brain tumors. I then outline a retrospective meta-analysis of brain tumor incidence rates in psychiatric patients presumed to be chronically taking neuromodulators similar to those identified in the initial screen.
    [Show full text]
  • ()-PHCCC, a Positive Allosteric Modulator of Mglur4
    Neuropharmacology 45 (2003) 895–906 www.elsevier.com/locate/neuropharm (Ϫ)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection M. Maj a,1, V. Bruno b,1, Z. Dragic a, R. Yamamoto a, G. Battaglia b, W. Inderbitzin a, N. Stoehr a, T. Stein a, F. Gasparini a, I. Vranesic a, R. Kuhn a, F. Nicoletti b,c, P.J. Flor a,∗ a Novartis Institutes for BioMedical Research, Neuroscience Disease Area, WKL-125.6.08, Basel CH-4002, Switzerland b Istituto Neurologico Mediterraneo, Neuromed, Pozzilli, Italy c Department of Human Physiology and Pharmacology, University of Rome, Rome, Italy Received 25 February 2003; received in revised form 27 May 2003; accepted 23 June 2003 Abstract Group-III metabotropic glutamate receptors (mGluR4, -6, -7, and -8) modulate neurotoxicity of excitatory amino acids and beta- amyloid-peptide (bAP), as well as epileptic convulsions, most likely via presynaptic inhibition of glutamatergic neurotransmission. Due to the lack of subtype-selective ligands for group-III receptors, we previously utilized knock-out mice to identify mGluR4 as + the primary receptor mediating neuroprotection of unselective group-III agonists such as L-AP4 or ( )-PPG, whereas mGluR7 is critical for anticonvulsive effects. In a recent effort to find group-III subtype-selective drugs we identified (+/Ϫ)-PHCCC as a positive allosteric modulator for mGluR4. This compound increases agonist potency and markedly enhances maximum efficacy and, at higher concentrations, directly activates mGluR4 with low efficacy. All the activity of (+/Ϫ)-PHCCC resides in the (Ϫ)-enantiomer, which is inactive at mGluR2, -3, -5a, -6, -7b and -8a, but shows partial antagonist activity at mGluR1b (30% maximum antagonist efficacy).
    [Show full text]
  • Small Molecule Screening Protocols
    Small Molecule Screening Workshop July 29th, 2013 Sapporo, Japan Molecular Biophysics Group Structural Genomics Consortium University of Toronto On the cover: Cytosolic sulfotransferase family of proteins was screened against a library of 90 compounds by a thermodenaturation-based method (DSLS). Structures of cytosolic sulfotransferases are clustered according to their binding site structural similarity and surrounded by the molecules used in the binding experiments (Allali-Hassani et al., 2007, PLoS Biology. PMID: 17425406). Welcome to the workshop As part of the SGC’s ongoing program in structural genomics of human and malaria proteins we are also identifying small molecules that bind and stabilize our proteins, thereby promoting crystallization. We have implemented two screening platforms, based on either fluorimetry or static light scattering, to measure the increase in protein thermal stability upon binding of a ligand without the need to monitor enzyme activity (Vedadi et al (2006) PNAS. 103 (43):15835-40). Identification of small molecules that bind to proteins can provide valuable information on protein specificity, activity, as well as a practical means to facilitate 3D structure determination. This workshop aims to provide an opportunity for you to learn how to implement differential scanning fluorimetry (DSF) technique. We would like to take the opportunity to welcome you to our workshop. Masoud Vedadi Contact Information Masoud Vedadi, Ph.D. Principal Investigator, Molecular Biophysics Structural Genomics Consortium, Assistant Professor, Department of Pharmacology and Toxicology, University of Toronto, MaRS Centre, South Tower 101 College St.7 Floor,Room 714 Toronto, ON, M5G 1L7 Tel: 416 946 0897 E-mail: [email protected] www.sgc.utoronto.ca/biophysics Prepared by: Dr.
    [Show full text]
  • Security Systems Services World Report
    Security Systems Services World Report established in 1974, and a brand since 1981. www.datagroup.org Security Systems Services World Report Database Ref: 56162 This database is updated monthly. Security Systems Services World Report SECURITY SYSTEMS SERVICES WORLD REPORT The Security systems services Report has the following information. The base report has 59 chapters, plus the Excel spreadsheets & Access databases specified. This research provides World Data on Security systems services. The report is available in several Editions and Parts and the contents and cost of each part is shown below. The Client can choose the Edition required; and subsequently any Parts that are required from the After-Sales Service. Contents Description ....................................................................................................................................... 5 REPORT EDITIONS ........................................................................................................................... 6 World Report ....................................................................................................................................... 6 Regional Report ................................................................................................................................... 6 Country Report .................................................................................................................................... 6 Town & Country Report ......................................................................................................................
    [Show full text]
  • Characterization of Vixotrigine, a Broad-Spectrum Voltage-Gated Sodium Channel Blocker S
    Supplemental material to this article can be found at: http://molpharm.aspetjournals.org/content/suppl/2021/04/02/99.1.49.DC1 1521-0111/99/1/49–59$35.00 https://doi.org/10.1124/molpharm.120.000079 MOLECULAR PHARMACOLOGY Mol Pharmacol 99:49–59, January 2021 Copyright ª 2020 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. Characterization of Vixotrigine, a Broad-Spectrum Voltage-Gated Sodium Channel Blocker s Christopher A Hinckley, Yuri Kuryshev, Alissende Sers, Alexander Barre, Bruno Buisson, Himanshu Naik, and Mihaly Hajos1 Biogen, Cambridge, Massachusetts (C.A.H., H.N.); Charles River Laboratories Cleveland, Inc., Cleveland, Ohio (Y.K.); Neuroservice, Aix-en-Provence, France (A.S., A.B., B.B.); and Department of Comparative Medicine, Yale University, New Haven, Connecticut (M.H.) Received June 8, 2020; accepted October 15, 2020 Downloaded from ABSTRACT Voltage-gated sodium channels (Navs) are promising targets for profound state-dependent inhibition but a similar broad analgesic and antiepileptic therapies. Although specificity be- spectrum of action distinct from Nav1.7- and Nav1.8-specific tween Nav subtypes may be desirable to target specific neural blockers. We find that vixotrigine rapidly inhibits Navs and types, such as nociceptors in pain, many broadly acting Nav prolongs recovery from the fast-inactivated state. In native molpharm.aspetjournals.org inhibitors are clinically beneficial in neuropathic pain and rodent dorsal root ganglion sodium channels, we find that epilepsy. Here, we present the first systematic characterization vixotrigine shifts steady-state inactivation curves. Based on of vixotrigine, a Nav blocker.
    [Show full text]
  • Dr. Craig W. Lindsley, FRSC
    Dr. Craig W. Lindsley, FRSC Home Address: Laboratory Address I: Laboratory Address II: 9281 Wardley Park Lane Department of Pharmacology VCNDD – Cool Springs Brentwood, TN 37027 MRBIV (Langford), 12478B Innovation Park (615)-891-1470 Vanderbilt Medical Center 393 Nichol Mills Road Nashville, TN 37232-6600 Franklin, TN 37027 E-mail: [email protected]; phone (office): 615-322-8700 Web sites: www.lindsleylab.com; www.vcndd.org; www.appellopharma.com Citizenship: US Date of Birth: February 7, 1970 Marital status: Married (Stacey), six children: Cameron (13), Jayma (11), Paige (10), Madison (6), Logan (4), Luke (2) Education: 1997 – 1999 Postdoctoral Fellow, Harvard University, Cambridge, MA 1992 - 1996 Ph.D., University of California, Santa Barbara, Santa Barbara, CA 1988 - 1992 B.S., Chemistry, California State University, Chico, Chico, CA Academic Appointments, Industrial Positions, Leadership Roles and Research Experience: 01/2018-present University Professor of Chemistry, University Professor of Pharmacology, University Professor of Biochemistry William K. Warren, Jr. Chair in Medicine, Co-Director and Director of Medicinal Chemistry and DMPK, Vanderbilt Center for Neuroscience Drug Discovery; Site Head, VCNDD Cool Springs Innovation Park; Editor-in-Chief, ACS Chemical Neuroscience Member, Vanderbilt Institute of Chemical Biology, VU-Ingram Cancer Center, Vanderbilt Center for Addiction Research Vanderbilt University School of Medicine, Vanderbilt University (Medicinal Chemistry, Drug Discovery, Total Synthesis, Chemical Biology)
    [Show full text]